Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 65 points (0.4%) at 18,102 as of Wednesday, April 15, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,063 issues advancing vs. 945 declining with 156 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.4%. A company within the industry that increased today was Boston Scientific ( BSX), up 0.9%. On the negative front, top decliners within the industry include UnitedHealth Group ( UNH), down 2.6%, and Humana ( HUM), down 2.0%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Quest Diagnostics ( DGX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Quest Diagnostics is up $1.43 (1.9%) to $75.93 on average volume. Thus far, 952,694 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $74.94-$76.23 after having opened the day at $75.01 as compared to the previous trading day's close of $74.50.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. Quest Diagnostics has a market cap of $10.9 billion and is part of the health care sector. Shares are up 11.1% year-to-date as of the close of trading on Tuesday. Currently there are 2 analysts who rate Quest Diagnostics a buy, 4 analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, solid stock price performance, growth in earnings per share and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Quest Diagnostics Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, St Jude Medical ( STJ) is up $0.74 (1.1%) to $68.11 on light volume. Thus far, 543,364 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $67.52-$68.18 after having opened the day at $67.52 as compared to the previous trading day's close of $67.37.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical has a market cap of $19.0 billion and is part of the health care sector. Shares are up 3.6% year-to-date as of the close of trading on Tuesday. Currently there are 16 analysts who rate St Jude Medical a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and reasonable valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full St Jude Medical Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, HCA Holdings ( HCA) is up $1.87 (2.4%) to $79.21 on heavy volume. Thus far, 4.2 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 5.1 million shares. The stock has ranged in price between $78.48-$80.20 after having opened the day at $79.12 as compared to the previous trading day's close of $77.34.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $32.5 billion and is part of the health care sector. Shares are up 5.4% year-to-date as of the close of trading on Tuesday. Currently there are 15 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null